ClinicalTrials.Veeva

Menu

Noninvasive Mapping Before Surgical Ablation (NIMSA)

Medical University of Vienna logo

Medical University of Vienna

Status

Active, not recruiting

Conditions

Atrial Fibrillation (AF)

Treatments

Device: Electrocardiographic imaging

Study type

Observational

Funder types

Other

Identifiers

NCT06803615
1046/2018

Details and patient eligibility

About

The purpose of this study is to assess the electrophysiological mechanism of atrial fibrillation by means of a beat-to-beat noninvasive 3D mapping method in patients with concomitant persistent and long-standing persistent atrial fibrillation undergoing surgical ablation.

Enrollment

51 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • legal age (18-90a)
  • life expectancy > 2 years
  • patients suffering from persistent and long standing atrial fibrillation
  • scheduled for concomitant surgical ablation
  • possibility to follow-up
  • given informed consent

Exclusion criteria

  • vulnerable patient groups

  • pregnancy

  • any previous surgical ablation

  • acute surgical indications

  • any physical condition that leads to a life expectancy of less than two years

  • any contraindication to the treatments necessary for the trial's conduction as e.g.

    • known allergic reaction to contrast agent
    • known allergic reaction to antiarrhythmic drugs
    • claustrophobia or anxiety in small spaces
    • severe renal impairment
    • unmanageable hyperthyroidism
  • participation in any other clinical trial that either excludes enrolment or may be a confounding factor to results

  • voluntary retention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems